Joint Formulary & PAD

Insulin degludec with liraglutide - Diabetes Mellitus

You are here : Home > Formulary Search > Insulin degludec with liraglutide - Diabetes Mellitus

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
SPC
Restrictions / Comments :

Documentation

Policy Statement
Xultophy - Policy statement PCN 183-2016 - Feb 2016
Evidence Review
Xultophy - Evidence review - Dec 2015
Evidence Review
Xultophy - NICE evidence summary - Jul 2015
Information
GLP-1 medicines for weight loss and diabetes: what you need to know - MHRA guidance

PAD Profile

ChemicalSubstance :
Insulin degludec with liraglutide
Indication :
Diabetes Mellitus
Group Name :
Keywords :
insulin degludec and 3.6 mg/mL liraglutide, GLP-1s, long acting insulin analogues
Brand Names Include :
Xultophy
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Diabetes Mellitus
Supporting Documents :
4

Committee Recommendations (2)

03 Jun 20 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.

If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.

03 Feb 16 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN does not recommend the use of Xultophy (insulin degludec/liraglutide) and it will be considered BLACK on the traffic light system.

See policy statement and evidence reviews for further information

Other Indications

Below are listed other indications that Insulin degludec with liraglutide is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Diabetes Mellitus.